SPE Capital and Proparco exit Moroccan pharmaceutical group Amanys Pharma

By AfricaPost November 25, 2023187 views

Only three years after joining the shareholding of Amanys Pharma, a Moroccan antibiotics manufacturer and hospital supplier, private equity firm SPE

Source

Comments

Comments are closed.

More in Business

Business

China Boosts Investments in Africa to $29.2bn, Up 34% in 2024

1 day ago0

Business

Tackling Africa’s foundational learning crisis

1 day ago0

Business

State capture convictions will rise, says Batohi

1 day ago0

Business

Nigeria: Liv.ing Launches MVNO to Redefine Connectivity

2 days ago0

SPE Capital and Proparco exit Moroccan pharmaceutical group Amanys Pharma

United Arab Emirates President sends letter to President of Nigeria

A DEPUTY COUNTRY DIRECTOR – SUPPORT, November 2023 – NGO Jobs

Morocco Gets $496mln IMF Loan for Climate and Economic Resilience

Time to tear down Africa’s visa barriers

AI-Driven Fraud Surge Threatens Africa’s Security and Identity Systems

EDITORIAL: Current account good news for rand and economy

Comments

More in Business

China Boosts Investments in Africa to $29.2bn, Up 34% in 2024

Tackling Africa’s foundational learning crisis

State capture convictions will rise, says Batohi

Nigeria: Liv.ing Launches MVNO to Redefine Connectivity

Popular Posts

Family-owned florist business looks to bloom in Chestertown

Review: Nokia retunes 3310 for a new generation

Apple Watch: What does the future hold?

Asian stocks pull back on U.S. tech declines, eurozone worries

United Arab Emirates President sends letter to President of Nigeria

A DEPUTY COUNTRY DIRECTOR – SUPPORT, November 2023 – NGO Jobs

You may also like

Comments

More in Business

Popular Posts